Table 1

SNPs rs10484561 and rs6457327 association with risk of developing FL in the United Kingdom

SNP/genotypeGenotype count
MAF (cases/control)HWE controlsVariant allele OR (95% CI)Allelic OR (95% CI)Allelic PTrend PGenotypic P
Cases*Controls
rs10484561   0.21/0.11 0.924 2.40 (1.80-3.19) 2.07 (1.61-2.63) 3.502 × 10-9 2.743 × 10-9 6.342 × 10-9 
    GG 34        
    GT 82 548        
    TT 131 2102        
rs6457327   0.32/0.39 0.808 0.77 (0.58-1.01) 0.75 (0.61-0.93) .008 .008 .0190 
    AA 19 408        
    AC 103 1272        
    CC 96 1011        
SNP/genotypeGenotype count
MAF (cases/control)HWE controlsVariant allele OR (95% CI)Allelic OR (95% CI)Allelic PTrend PGenotypic P
Cases*Controls
rs10484561   0.21/0.11 0.924 2.40 (1.80-3.19) 2.07 (1.61-2.63) 3.502 × 10-9 2.743 × 10-9 6.342 × 10-9 
    GG 34        
    GT 82 548        
    TT 131 2102        
rs6457327   0.32/0.39 0.808 0.77 (0.58-1.01) 0.75 (0.61-0.93) .008 .008 .0190 
    AA 19 408        
    AC 103 1272        
    CC 96 1011        

MAF indicates minor allele frequency; HWE, Hardy-Weinberg equilibrium; and CI, confidence interval.

*

FL cases from St Bartholomew's Hospital (n = 218 for both SNPs). In a validation series (10% of FL cases), direct sequencing results for each SNP genotype were fully concordant with the AD-PCR genotype results.

Controls from WTCCC2 1958 birth cohort (after filtering for missing genotype, population outliers, and relatedness: n = 2684 for rs10484561; n = 2691 for rs6457327). Both control populations maintain HWE.

ORs calculated for the variant allele carriers (homozygous or heterozygous) vs homozygous common allele carriers (Variant allele OR) and for the minor vs the major allele (Allelic OR).